Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Capital Expenditures (2016 - 2025)

CorMedix (CRMD) has disclosed Capital Expenditures for 12 consecutive years, with $1.7 million as the latest value for Q4 2025.

  • Quarterly Capital Expenditures rose 16865.22% to $1.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.3 million through Dec 2025, up 1848.28% year-over-year, with the annual reading at $2.3 million for FY2025, 1848.28% up from the prior year.
  • Capital Expenditures hit $1.7 million in Q4 2025 for CorMedix, up from $505774.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $1.7 million in Q4 2025 to a low of $4324.0 in Q1 2022.
  • Historically, Capital Expenditures has averaged $237379.7 across 5 years, with a median of $23945.0 in 2025.
  • Biggest five-year swings in Capital Expenditures: crashed 90.18% in 2022 and later skyrocketed 16865.22% in 2025.
  • Year by year, Capital Expenditures stood at $628761.0 in 2021, then tumbled by 79.52% to $128755.0 in 2022, then plummeted by 88.53% to $14766.0 in 2023, then plummeted by 31.34% to $10139.0 in 2024, then surged by 16865.22% to $1.7 million in 2025.
  • Business Quant data shows Capital Expenditures for CRMD at $1.7 million in Q4 2025, $505774.0 in Q3 2025, and $23945.0 in Q2 2025.